GLP-1 & Metabolic
Metabolic health, appetite regulation, and modern weight management.
85 articles in GLP-1 & Metabolic · page 2 of 8
GLP-2T Explained: The Dual-Agonist Product Code and the Evidence
GLP-2T is a vendor code for a tirzepatide-class dual agonist. The drug-class science is strong; the vial in your hand is unverified. The honest split.
Read →GLP-3R Explained: The Triple-Agonist Product Code and the Evidence
GLP-3R is a vendor product code for a retatrutide-class triple agonist. The science is real and phase 2; the grey-market vial is not the drug.
Read →Are GLP-1s Safe Long-Term?
GLP-1 drugs have over a decade of use in diabetes and a growing but shorter track record in obesity. What the multi-year data shows, and what it still can't answer.
Read →Cagrilintide: The Amylin Analog, Explained
Cagrilintide mimics a lesser-known pancreatic hormone called amylin. Paired with semaglutide as CagriSema, it's Novo Nordisk's next bet in obesity treatment, but it isn't approved on its own yet.
Read →GLP-1s and Constipation: Managing the Other GI Effect
Nausea gets the headlines, but constipation is one of the most common GLP-1 side effects. Why it happens, and what helps.
Read →GLP-1s in Pregnancy and Before Conception
GLP-1 drugs are not recommended in pregnancy, and labels call for stopping them weeks to months before trying to conceive. Here's what's known, what isn't, and why 'Ozempic babies' are a real phenomenon.
Read →"Ozempic Face": Facial Aging and Rapid Fat Loss
"Ozempic face" is what happens to facial volume when anyone loses weight quickly, not a drug side effect in the pharmacological sense. Here's the mechanism and what can be done about it.
Read →Ozempic vs Mounjaro: Which and For Whom
Ozempic (semaglutide) and Mounjaro (tirzepatide) are both type-2-diabetes drugs with weight-loss effects, but they work on different receptors and have different evidence bases. How to think about the choice.
Read →Retatrutide vs Tirzepatide: Triple vs Dual Agonist
Tirzepatide targets two hormone receptors and is FDA-approved. Retatrutide adds a third and posted larger early weight-loss numbers, but it's still an investigational drug.
Read →Stopping a GLP-1 Before Surgery: The Anesthesia Guidance
GLP-1 drugs slow stomach emptying, and that can matter under anesthesia even after a normal fast. Here's what anesthesiologists are actually recommending.
Read →What Is Ozempic? A Plain-Language Explainer
Ozempic is a weekly injectable diabetes medicine that has become a household name. Here's what it is, how it works, and how it differs from Wegovy and Rybelsus.
Read →What Is Zepbound? A Plain-Language Explainer
Zepbound is Eli Lilly's weekly injectable for chronic weight management. What tirzepatide is, what the trials showed, and how it differs from Mounjaro.
Read →